Anti-Adrenodoxin 抗体 [EPR4630] (ab109312)

製品の概要

  • 製品名Anti-Adrenodoxin antibody [EPR4630]
    Adrenodoxin 一次抗体 製品一覧
  • 製品の詳細
    Rabbit monoclonal [EPR4630] to Adrenodoxin
  • アプリケーション適用あり: IP, WB, ICC/IFmore details
    適用なし: Flow Cyt or IHC-P
  • 種交差性
    交差種: Mouse, Rat, Human
  • 免疫原

    Synthetic peptide (the amino acid sequence is considered to be commercially sensitive) (internal sequence)

  • ポジティブ・コントロール
    • Human placenta, Human thyroid and A549 lysates; A549 cells
  • 特記事項

    This product is a recombinant rabbit monoclonal antibody.

    Produced using Abcam’s RabMAb® technology. RabMAb® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.

製品の特性

アプリケーション

Our Abpromise guarantee covers the use of ab109312 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

アプリケーション Abreviews 特記事項
IP 1/10 - 1/100.
WB 1/1000 - 1/10000. Detects a band of approximately 14 kDa (predicted molecular weight: 19 kDa).
ICC/IF 1/50 - 1/100.
  • 追加情報Is unsuitable for Flow Cyt or IHC-P.
  • ターゲット情報

    Anti-Adrenodoxin antibody [EPR4630] 画像

    • All lanes : Anti-Adrenodoxin antibody [EPR4630] (ab109312) at 1/1000 dilution

      Lane 1 : Human placenta lysate
      Lane 2 : Human thyroid lysate
      Lane 3 : A549 lysate

      Lysates/proteins at 10 µg per lane.


      Predicted band size : 19 kDa
      Observed band size : 14 kDa (why is the actual band size different from the predicted?)
    • Immunofluorescent analysis of Adrenodoxin in A549 cells using ab109312 at 1/50 dilution.

    Anti-Adrenodoxin antibody [EPR4630] (ab109312) 使用論文

    ab109312 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab109312.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"